Susan M. Swetter, MD

Articles by Susan M. Swetter, MD

Unique Case Documents Involution of Nevi on BRAF/MEK Inhibitors

November 14th 2014

In this interview we discuss a patient who experienced regression of BRAF-inhibitor-induced eruptive melanocytic nevi following concomitant addition of a MEK inhibitor.

Melanoma in the Older Person

BySusan M. Swetter, MD,Alan C. Geller, MPH, RN,John M. Kirkwood, MD

August 1st 2004

Melanoma incidence and mortality continue to rise unabated in older individuals. Early clinical detection should take into account the different subtypes.

Latest Updated Articles

Unique Case Documents Involution of Nevi on BRAF/MEK Inhibitors
November 14th 2014
Melanoma in the Older Person
August 1st 2004

Trending on CancerNetwork

FDA Approves Zenocutuzumab in NRG1+ Cholangiocarcinoma Post Systemic Therapy

Daraxonrasib Shows Anti-Tumor Activity in Pretreated RAS+ Pancreatic Cancer

FDA Clears AI Stratification Tool in HR+/HER2– Invasive Breast Cancer

TIP125 ReDiscover-2, a Phase 3 Study of Zovegalisib (RLY-2608) + Fulvestrant Versus Capivasertib + Fulvestrant as Treatment for Locally Advanced or Metastatic PIK3CA-Mutant HR+/ HER2- Breast Cancer Following Recurrence or Progression on or After Treatment With a CDK4/6 Inhibitor (Trial in Progress)